Literature DB >> 33497357

Distinct antibody repertoires against endemic human coronaviruses in children and adults.

Taushif Khan1, Mahbuba Rahman1, Fatima Al Ali1, Susie S Y Huang1, Manar Ata1, Qian Zhang2, Paul Bastard2,3,4, Zhiyong Liu2, Emmanuelle Jouanguy2,3,4, Vivien Béziat2,3,4, Aurélie Cobat2,3,4, Gheyath K Nasrallah5,6, Hadi M Yassine5,6, Maria K Smatti6, Amira Saeed7, Isabelle Vandernoot8, Jean-Christophe Goffard9, Guillaume Smits8, Isabelle Migeotte10, Filomeen Haerynck11, Isabelle Meyts12,13, Laurent Abel2,3,4, Jean-Laurent Casanova2,3,4,14, Mohammad R Hasan7,15, Nico Marr1,16.   

Abstract

Four endemic human coronaviruses (HCoVs) are commonly associated with acute respiratory infection in humans. B cell responses to these "common cold" viruses remain incompletely understood. Here we report a comprehensive analysis of CoV-specific antibody repertoires in 231 children and 1168 adults using phage immunoprecipitation sequencing. Seroprevalence of antibodies against endemic HCoVs ranged between approximately 4% and 27% depending on the species and cohort. We identified at least 136 novel linear B cell epitopes. Antibody repertoires against endemic HCoVs were qualitatively different between children and adults in that anti-HCoV IgG specificities more frequently found among children targeted functionally important and structurally conserved regions of the spike, nucleocapsid, and matrix proteins. Moreover, antibody specificities targeting the highly conserved fusion peptide region and S2' cleavage site of the spike protein were broadly cross-reactive with peptides of epidemic human and nonhuman coronaviruses. In contrast, an acidic tandem repeat in the N-terminal region of the Nsp3 subdomain of the HCoV-HKU1 polyprotein was the predominant target of antibody responses in adult donors. Our findings shed light on the dominant species-specific and pan-CoV target sites of human antibody responses to coronavirus infection, thereby providing important insights for the development of prophylactic or therapeutic monoclonal antibodies and vaccine design.

Entities:  

Keywords:  Immunoglobulins; Immunology; Infectious disease

Year:  2021        PMID: 33497357     DOI: 10.1172/jci.insight.144499

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  15 in total

1.  IgG targeting distinct seasonal coronavirus- conserved SARS-CoV-2 spike subdomains correlates with differential COVID-19 disease outcomes.

Authors:  Jose L Garrido; Matías A Medina; Felipe Bravo; Sarah McGee; Francisco Fuentes-Villalobos; Mario Calvo; Yazmin Pinos; James W Bowman; Christopher D Bahl; Maria Ines Barria; Rebecca A Brachman; Raymond A Alvarez
Journal:  Cell Rep       Date:  2022-05-16       Impact factor: 9.995

2.  SARS-CoV-2 and endemic coronaviruses: Comparing symptom presentation and severity of symptomatic illness among Nicaraguan children.

Authors:  Aaron M Frutos; John Kubale; Guillermina Kuan; Sergio Ojeda; Nivea Vydiswaran; Nery Sanchez; Miguel Plazaola; May Patel; Roger Lopez; Angel Balmaseda; Aubree Gordon
Journal:  PLOS Glob Public Health       Date:  2022-05-25

3.  Immunological memory to common cold coronaviruses assessed longitudinally over a three-year period pre-COVID19 pandemic.

Authors:  Esther Dawen Yu; Tara M Narowski; Eric Wang; Emily Garrigan; Jose Mateus; April Frazier; Daniela Weiskopf; Alba Grifoni; Lakshmanane Premkumar; Ricardo da Silva Antunes; Alessandro Sette
Journal:  Cell Host Microbe       Date:  2022-07-20       Impact factor: 31.316

4.  SARS-CoV-2 and endemic coronaviruses: Comparing symptom presentation and severity of symptomatic illness among Nicaraguan children.

Authors:  Aaron M Frutos; John Kubale; Guillermina Kuan; Sergio Ojeda; Nivea Vydiswaran; Nery Sanchez; Miguel Plazaola; May Patel; Roger Lopez; Angel Balmaseda; Aubree Gordon
Journal:  medRxiv       Date:  2022-02-03

5.  Inherited IFNAR1 Deficiency in a Child with Both Critical COVID-19 Pneumonia and Multisystem Inflammatory Syndrome.

Authors:  Hassan Abolhassani; Nils Landegren; Paul Bastard; Marie Materna; Mohammadreza Modaresi; Likun Du; Maribel Aranda-Guillén; Fabian Sardh; Fanglei Zuo; Peng Zhang; Harold Marcotte; Nico Marr; Taushif Khan; Manar Ata; Fatima Al-Ali; Remi Pescarmona; Alexandre Belot; Vivien Béziat; Qian Zhang; Jean-Laurent Casanova; Olle Kämpe; Shen-Ying Zhang; Lennart Hammarström; Qiang Pan-Hammarström
Journal:  J Clin Immunol       Date:  2022-01-28       Impact factor: 8.542

6.  Antibody conversion rates to SARS-CoV-2 in saliva from children attending summer schools in Barcelona, Spain.

Authors:  Carlota Dobaño; Selena Alonso; Gemma Moncunill; Iolanda Jordan; Mariona Fernández de Sevilla; Marta Vidal; Alfons Jiménez; Gemma Pons Tomas; Chenjerai Jairoce; María Melé Casas; Rocío Rubio; María Hernández García; Gemma Ruiz-Olalla; Mònica Girona-Alarcón; Diana Barrios; Rebeca Santano; Robert A Mitchell; Laura Puyol; Leonie Mayer; Jordi Chi; Natalia Rodrigo Melero; Carlo Carolis; Aleix Garcia-Miquel; Elisenda Bonet-Carne; Joana Claverol; Marta Cubells; Claudia Fortuny; Victoria Fumadó; Cristina Jou; Carmen Muñoz-Almagro; Luis Izquierdo; Quique Bassat; Eduard Gratacós; Ruth Aguilar; Juan José García-García
Journal:  BMC Med       Date:  2021-11-23       Impact factor: 8.775

7.  Multiplex Antibody Analysis of IgM, IgA and IgG to SARS-CoV-2 in Saliva and Serum From Infected Children and Their Close Contacts.

Authors:  Carlota Dobaño; Selena Alonso; Marta Vidal; Alfons Jiménez; Rocío Rubio; Rebeca Santano; Diana Barrios; Gemma Pons Tomas; María Melé Casas; María Hernández García; Mònica Girona-Alarcón; Laura Puyol; Barbara Baro; Pere Millat-Martínez; Sara Ajanovic; Núria Balanza; Sara Arias; Natalia Rodrigo Melero; Carlo Carolis; Aleix García-Miquel; Elisenda Bonet-Carné; Joana Claverol; Marta Cubells; Claudia Fortuny; Victoria Fumadó; Anna Codina; Quique Bassat; Carmen Muñoz-Almagro; Mariona Fernández de Sevilla; Eduard Gratacós; Luis Izquierdo; Juan José García-García; Ruth Aguilar; Iolanda Jordan; Gemma Moncunill
Journal:  Front Immunol       Date:  2022-01-27       Impact factor: 7.561

8.  Immunological memory to Common Cold Coronaviruses assessed longitudinally over a three-year period.

Authors:  Esther Dawen Yu; Tara M Narowski; Eric Wang; Emily Garrigan; Jose Mateus; April Frazier; Daniela Weiskopf; Alba Grifoni; Lakshmanane Premkumar; Ricardo da Silva Antunes; Alessandro Sette
Journal:  bioRxiv       Date:  2022-03-02

9.  Humans with inherited T cell CD28 deficiency are susceptible to skin papillomaviruses but are otherwise healthy.

Authors:  Vivien Béziat; Franck Rapaport; Jiafen Hu; Matthias Titeux; Mathilde Bonnet des Claustres; Mathieu Bourgey; Heather Griffin; Élise Bandet; Cindy S Ma; Roya Sherkat; Hassan Rokni-Zadeh; David M Louis; Majid Changi-Ashtiani; Ottavia M Delmonte; Toshiaki Fukushima; Tanwir Habib; Andrea Guennoun; Taushif Khan; Noemi Bender; Mahbuba Rahman; Frédégonde About; Rui Yang; Geetha Rao; Claire Rouzaud; Jingwei Li; Debra Shearer; Karla Balogh; Fatima Al Ali; Manar Ata; Soroosh Dabiri; Mana Momenilandi; Justine Nammour; Marie-Alexandra Alyanakian; Marianne Leruez-Ville; David Guenat; Marie Materna; Léa Marcot; Natasha Vladikine; Christine Soret; Hassan Vahidnezhad; Leila Youssefian; Amir Hossein Saeidian; Jouni Uitto; Émilie Catherinot; Shadi Sadat Navabi; Mohammed Zarhrate; David T Woodley; Mohamed Jeljeli; Thomas Abraham; Serkan Belkaya; Lazaro Lorenzo; Jérémie Rosain; Mousa Bayat; Fanny Lanternier; Olivier Lortholary; Faramarz Zakavi; Philippe Gros; Gérard Orth; Laurent Abel; Jean-Luc Prétet; Sylvie Fraitag; Emmanuelle Jouanguy; Mark M Davis; Stuart G Tangye; Luigi D Notarangelo; Nico Marr; Tim Waterboer; David Langlais; John Doorbar; Alain Hovnanian; Neil Christensen; Xavier Bossuyt; Mohammad Shahrooei; Jean-Laurent Casanova
Journal:  Cell       Date:  2021-07-01       Impact factor: 66.850

10.  Functional Analysis of Human and Feline Coronavirus Cross-Reactive Antibodies Directed Against the SARS-CoV-2 Fusion Peptide.

Authors:  Nathalie Vanderheijden; Annelies Stevaert; Jiexiong Xie; Xiaolei Ren; Cyril Barbezange; Sam Noppen; Isabelle Desombere; Bruno Verhasselt; Peter Geldhof; Nick Vereecke; Veerle Stroobants; Dayoung Oh; Merijn Vanhee; Lieve M J Naesens; Hans J Nauwynck
Journal:  Front Immunol       Date:  2022-01-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.